title: T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.
abstract: Activation-induced cell surface molecules are involved in mediating bidirectional T-B lymphocyte signaling that is important in the induction of T or B lymphocyte effector functions. In this regard, T-BAM/CD40-L is an activation-induced CD4+ T cell surface molecule known to be important in inducing B cell effector functions. This report demonstrates that T-BAM/CD40-L molecules on a Jurkat T cell leukemia subclone (D1.1) or nonlymphoid 293 kidney cell transfectants induce B cells or B-CLL cells to express CD80 (B7/BB-1) in a manner that is specifically inhibited by anti-T-BAM/CD40-L mAb 5C8. Because activation-induced B cell surface molecules, such as CD80, deliver costimulatory signals to T cells that augment T cell proliferation, the functional costimulatory capacity of T-BAM/CD40-L-primed B cells and B-CLL cells was studied. T-BAM/CD40-L-primed B cells or B-CLL cells augment the proliferative responses of allogenic T cells. Furthermore, T-BAM/CD40-L priming is specifically inhibited by mAb 5C8. Together, these studies demonstrate that T-BAM/CD40-L induces CD80 expression on resting B cells or B-CLL cells. Moreover, T-BAM/CD40-L signaling enhances B cell costimulatory capacity. These studies suggest that T-BAM/CD40-L molecules not only induce B cell differentiative processes that result in Ab secretion, but also enable B cells to prime Ag-specific T cells for subsequent clonal expansion.
authors.affiliation: Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
authors.forename: M J
authors.initials: MJ
authors.lastname: Yellin
authors.forename: J
authors.initials: J
authors.lastname: Sinning
authors.forename: L R
authors.initials: LR
authors.lastname: Covey
authors.forename: W
authors.initials: W
authors.lastname: Sherman
authors.forename: J J
authors.initials: JJ
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Glickman-Nir
authors.forename: K C
authors.initials: KC
authors.lastname: Sippel
authors.forename: J
authors.initials: J
authors.lastname: Rogers
authors.forename: A M
authors.initials: AM
authors.lastname: Cleary
authors.forename: M
authors.initials: M
authors.lastname: Parker
mesh_terms: D001402:B-Lymphocytes / Q000276:immunology*; D018122:B7-1 Antigen / Q000032:analysis*; D023201:CD40 Ligand; D002460:Cell Line; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood*; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000502:physiology*; D017455:Receptors, IgE / Q000032:analysis
chemical_list: D018122:B7-1 Antigen; D008562:Membrane Glycoproteins; D017455:Receptors, IgE; D023201:CD40 Ligand